2024
Review and analysis of history and utilization of panretinal photocoagulation and ranibizumab after publication of protocol S
Shah S, Chou B, Patel M, Watane A, Shah L, Yannuzzi N, Sridhar J. Review and analysis of history and utilization of panretinal photocoagulation and ranibizumab after publication of protocol S. Current Opinion In Ophthalmology 2024, 35: 369-375. PMID: 39115058, DOI: 10.1097/icu.0000000000001076.Peer-Reviewed Original Research
2023
Do published trial results influence physician prescribing patterns? Intravitreal antivascular endothelial growth factor usage by the United States Ophthalmologists before and after Protocol T study
Shah S, Markatia Z, Watane A, Feldman A, Shah L, Sridhar J. Do published trial results influence physician prescribing patterns? Intravitreal antivascular endothelial growth factor usage by the United States Ophthalmologists before and after Protocol T study. Current Opinion In Ophthalmology 2023, 34: 218-225. PMID: 36866850, DOI: 10.1097/icu.0000000000000944.Peer-Reviewed Original ResearchMeSH KeywordsAngiogenesis InhibitorsBevacizumabDiabetic RetinopathyEndothelial Growth FactorsHumansIntravitreal InjectionsOphthalmologistsPractice Patterns, Physicians'RanibizumabReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsReview Literature as TopicUnited StatesVascular Endothelial Growth Factor AVisual AcuityConceptsDiabetic macular edemaClinical trial publicationsAflibercept injectionsTrial publicationsAntivascular endothelial growth factor medicationsTreatment of DMEAnti-VEGF agentsGrowth factor usageMacular edemaVEGF agentsLabel bevacizumabT studyTrial resultsBevacizumabYear of publicationMean proportionAverage numberPhysiciansFactor usageTreatmentInjectionIndicationsYearsAfliberceptMedications
2021
FOLLOW-UP ADHERENCE IN PATIENTS WITH NONPROLIFERATIVE DIABETIC RETINOPATHY PRESENTING TO AN OPHTHALMIC EMERGENCY DEPARTMENT
Watane A, Kalavar M, Vanner EA, Cavuoto K, Sridhar J. FOLLOW-UP ADHERENCE IN PATIENTS WITH NONPROLIFERATIVE DIABETIC RETINOPATHY PRESENTING TO AN OPHTHALMIC EMERGENCY DEPARTMENT. Retina 2021, 41: 1293-1301. PMID: 33252579, DOI: 10.1097/iae.0000000000003037.Peer-Reviewed Original ResearchConceptsNonproliferative diabetic retinopathyDiabetic retinopathyNon-proliferative diabetic retinopathyOphthalmic emergency departmentRetrospective cohort studyLonger physicianCohort studyOverall followMacular edemaWorse visionEmergency departmentHigh riskPatientsCommercial insuranceFollowRetinopathyEmergent encountersAdherenceEncounter dataEncounter characteristicsHigh-income areasHome distanceLonger intervalsOddsIncome areas